APAna Cláudia Chagas de Paula

Ana Cláudia Chagas de Paula

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Cláudia Chagas de Paula has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Metabolome of the Ocotea spp.: From Biosynthetic Aspects to Bioactive Chemical Scaffolds by Integrating the Genus Chemical Database ( Ocotea DB)

    by Albert Katchborian-Neto, Karen de Jesus Nicácio, Paula Carolina Pires Bueno, Miller Santos Ferreira, Matheus Fernandes Alves, Daniele de Oliveira Silva, Wanderleya Toledo dos Santos, Marina de Monroe Gonçalves, Ana Claudia Chagas de Paula, Danielle Ferreira Dias, et al.

    The genus Ocotea is a significant source of bioactive agents within the Lauraceae, yet it remains underexplored. Despite its ethnomedicinal relevance and chemical diversity, Ocotea species remain taxonomically challenging as they belong to the multifaceted “Ocotea complex”, a phylogenetically unresolved group. Moving beyond previous literature Ocotea surveys, this review provides the first curated, genus-specific data set of both volatile and nonvolatile specialized metabolites. Covering research articles from 1830 to 2025, this review provides the most comprehensive synthesis to date, documenting 984 unique chemical compounds across 115 species. This effort culminated in the construction of the Ocotea Chemical Database (OcoteaDB), a novel digital resource created to streamline the genus’s chemical diversity for the global scientific community. Furthermore, it presents current knowledge of biosynthetic routes leading to key bioactive scaffolds, including aporphinoid and benzylisoquinoline alkaloids, lignoids, glycosylated flavonoids, and a diverse array of terpenoids, while addressing the stereochemical and structural intricacies unique to the genus. This review lays a robust foundation to drive future Ocotea-focused bioprospecting studies and guides research in the fields of natural products, chemophenetics, metabolomics, and medicinal chemistry regarding the Ocotea species, its chemical scaffolds, and specialized metabolites.


  • CYTOTOXIC EFFECT OF PUMPKIN SEED OIL-LOADED NANOEMULSION IN BREAST CANCER CELL LINES

    by Anelise Pereira Alves, Wanderleya Toledo dos Santos, Daniel Augusto de Andrade, Felipe Kelmer Müller, Kézia Cristine Barbosa Ferreira, Guilherme Diniz Tavares, Fabiano Freire Costa, Paula Rocha Chellini, Ana Cláudia Chagas de Paula

  • Open Access

    Antiproliferative Activity Screening in Ocotea spp. Reveals Active Compounds in O. villosa with a Promising Mechanism of Action against Human Breast Cancer Cell Line MCF-7

    by Fernanda Brito Leite Dornelas, Wanderleya Toledo dos Santos, Vanessa Viana Lempk, Juliana Leal Rodrigues da Costa, Clarissa Ferreira Cunha, Michael Murgu, Matheus Fernandes Alves, Albert Katchborian-Neto, José Otávio Do Amaral Corrêa, Daniela Aparecida Chagas-Paula, et al.

    Breast cancer is a global public health challenge, being the most prevalent cancer and the leading cause of cancer-related mortality among women worldwide. About half of the cases occur without specific risk factors. The biological heterogeneity of the disease, including distinct molecular subtypes, variable aggressiveness, and differential treatment responses, combined with its increasing incidence, makes its management particularly complex. Furthermore, current treatments often cause severe side effects, chronic toxicity, and negatively impact patients’ quality of life. Consequently, there is an urgent need for new, safer, and more effective therapies. Natural agents are particularly capable of targeting multiple molecular pathways, which could overcome therapeutic resistance, modulate the tumor microenvironment, and induce fewer and milder adverse effects. Some species of the Ocotea genus have demonstrated encouraging antiproliferative activity. However, the activity against breast cancer of most species of this genus and their active compounds remains poorly investigated. Thus, this study screened 56 Ocotea species extracts for in vitro cytotoxic activity against MCF-7 human breast cancer cells. Among the tested species, only the crude extract of O. villosa leaf (CE) exhibited a significant cytotoxicity against MCF-7 (IC50 = 100.00 ± 6.06 μg/mL; selective index, SI = 1.3). Metabolomic profiling revealed high levels of alkaloids in CE, including chemical annotations of major aporphine compounds (e.g., nuciferine-derived alkaloids). Mechanistic studies indicated that CE has pro-apoptotic activity, inducing apoptosis of 56.59% MCF-7 population, with an activity similar to 5-FU (53.8%), inhibiting cell migration by approximately 5%, and suppressing colony formation by around 50%, without significantly changing the cell cycle. Additionally, semiquantitative RT-PCR evidenced the overexpression of the pro-apoptotic marker CASP9, suggesting intrinsic apoptosis pathway activation by CE. These findings highlight the potential of O. villosa as a source of promising bioactive compounds for the development of anticancer therapies. The complex composition of CE provides various chemical scaffolds as lead compounds, supporting a multitarget mechanism of action with potential in the development of more effective anticancer therapies, reducing therapy resistance and decreasing adverse effects.


  • High‐Resolution Tandem Mass Spectrometry for Metabolic Profiling of Ocotea diospyrifolia (Meisn.) Mez Leaves

    by Matheus Fernandes Alves, Albert Katchborian Neto, Rosana Casoti, Fernanda Brito Leite, Ana Claudia Chagas de Paula, Danielle Ferreira Dias, Marisi Gomes Soares, Tiago Arruda Sanchez, Daniela Aparecida Chagas de Paula

    Ocotea is an important genus of Lauraceae plant family that comprises over 400 species, many of which pose challenges in taxonomic differentiation due to their complex botanical characteristics. Chemosystematics, and more recently, chemophenetics, have emerged as valuable tools to address these challenges based on their natural products (NPs) composition. O. diospyrifolia (Meisn.) Mez is a poorly studied species with known pharmacological potential. Here, we applied ultra‐high performance liquid chromatography coupled with high‐resolution tandem mass spectrometry (UHPLC‐HRMS) allied to a curated in‐house database with all previous isolated NPs from the Ocotea genus (OcoteaDB), gas phase fragmentations reactions, and biosynthesis. The strategy resulted in compounds annotated in confidence levels 2 (n=27), 3 (n=231), and 4 (n=21) according to the Metabolomics Standards Initiative (MSI). Additional annotations based on fragmentation proposals (n=16) were also included. The study revealed that O. diospyrifolia is a great alkaloid producer, even though different lignoids, which also comes from the shikimate pathway, were annotated. Additionally, the flavonoid profile predominantly consists of flavonol glycosides, complementing prior reports. This study provides the first comprehensive chemical profile of O. diospyrifolia leaves, which corroborates the chemotaxonomy of the species, and also contributes to further characterization studies, as the UHPLC‐HRMS data is publicly available.


  • Novel Synthesized Benzophenone Thiazole Hybrids Exhibited Ex Vivo and In Silico Anti‐Inflammatory Activity

    by Luiz Paulo Melchior de Oliveira Leão, Albert Katchborian Neto, Karen de Jesus Nicácio, Stefânia Neiva Lavorato, Fernanda Brito Leite, Karina Camargo Teixeira, Michael Murgu, Ana Cláudia Chagas de Paula, Marisi Gomes Soares, Daniela Aparecida Chagas‐Paula, et al.

    Novel benzophenone–thiazole hybrids with different substituents were synthesized and evaluated for anti‐inflammatory activity using an ex vivo human whole‐blood assay. All hybrids (3c and 5a–h) showed significant anti‐inflammatory activity via prostaglandin E2 (PGE2) release inhibition. Moreover, 5c (82.8% of PGE2 inhibition), 5e (83.1% of PGE2 inhibition), and 5h (82.1% of PGE2 inhibition) were comparable to the reference drugs. Molecular docking revealed potential preferable binding to the active sites of cyclooxygenase 2 (COX‐2) and microsomal prostaglandin E synthase‐1 (mPGES‐1) enzymes. This study provides the first evidence that benzophenone–thiazole hybrids may also dock in mPGES‐1, a new attractive anti‐inflammatory drug target, besides providing promising ex vivo anti‐inflammatory activity. Thus, the novel hybrids are promising anti‐inflammatory lead compounds and highlight the significance of optimal substituent selection in the design of potent PGE2 inhibitors.

  • Open Access

    Metabolomics Unveils Disrupted Pathways in Parkinson’s Disease: Toward Biomarker-Based Diagnosis

    by Wanderleya T. Santos, Albert Katchborian-Neto, Gabriel S. Viana, Miller S. Ferreira, Luiza C. Martins, Thiago C. Vale, Michael Murgu, Danielle F. Dias, Marisi G. Soares, Daniela A. Chagas-Paula, et al.

    Parkinson's disease (PD) is a neurodegenerative disorder characterized by diverse symptoms, where accurate diagnosis remains challenging. Traditional clinical observation methods often result in misdiagnosis, highlighting the need for biomarker-based diagnostic approaches. This study utilizes ultraperformance liquid chromatography coupled to an electrospray ionization source and quadrupole time-of-flight untargeted metabolomics combined with biochemometrics to identify novel serum biomarkers for PD. Analyzing a Brazilian cohort of serum samples from 39 PD patients and 15 healthy controls, we identified 15 metabolites significantly associated with PD, with 11 reported as potential biomarkers for the first time. Key disrupted metabolic pathways include caffeine metabolism, arachidonic acid metabolism, and primary bile acid biosynthesis. Our machine learning model demonstrated high accuracy, with the Rotation Forest boosting model achieving 94.1% accuracy in distinguishing PD patients from controls. It is based on three new PD biomarkers (downregulated: 1-lyso-2-arachidonoyl-phosphatidate and hypoxanthine and upregulated: ferulic acid) and surpasses the general 80% diagnostic accuracy obtained from initial clinical evaluations conducted by specialists. Besides, this machine learning model based on a decision tree allowed for visual and easy interpretability of affected metabolites in PD patients. These findings could improve the detection and monitoring of PD, paving the way for more precise diagnostics and therapeutic interventions. Our research emphasizes the critical role of metabolomics and machine learning in advancing our understanding of the chemical profile of neurodegenerative diseases.


  • Antiproliferative Potential of Essential Oil from the Leaves of Croton floribundus (Euphorbiaceae) Against Human Metastatic Melanoma Cell Lines

    by Daniela A. Garcia, Lara P. D. M. Costa, Welton Rosa, Ana C. C. P. Ladvocat, Danielle F. Dias, Marisi G. Soares, Marisa Ionta, Daniela A. Chagas‐Paula

    Melanoma is a cancer type with high lethality, metastatic capacity, and limited therapeutic options. Different essential oils have been reported with antitumoral potential. Thus, the essential oil (EO) of the leaves of C. floribundus was obtained by hydrodistillation and analyzed by GC‐MS. The majority of substances annotated were β‐selinene, E‐Caryophyllene, and Premnaspirodiene. The cytotoxic activity of EO was evaluated on three melanoma cell lines SKMEL‐147, WM‐1366, and CHL‐1, which are representative of metastatic melanoma with different mutation profiles. The IC50 values found for EO were lower than temozolomide (reference drug) in all melanoma cell lines. In addition, the selectivity of EO was upward when compared to the reference drug. Interestingly, the WM‐1366 cell line was the most responsive, and these findings are very promising considering that it has shown high resistance to the plethora of compounds. Thus, the C. floribundus EO is a promising source to drive further studies for the development of new treatments for metastatic melanoma, which is urgently relevant given the resistance of this pathology to current treatments.


  • Open Access

    LC-MS/DIA-based strategy for comprehensive flavonoid profiling: an Ocotea spp. applicability case

    by Matheus Fernandes Alves, Albert Katchborian-Neto, Paula Carolina Pires Bueno, Fausto Carnevale-Neto, Rosana Casoti, Miller Santos Ferreira, Michael Murgu, Ana Claudia Chagas de Paula, Danielle Ferreira Dias, Marisi Gomes Soares, et al.

    We introduce a liquid chromatography – mass spectrometry with data-independent acquisition (LC-MS/DIA)-based strategy, specifically tailored to achieve comprehensive and reliable glycosylated flavonoid profiling. This approach facilitates in-depth and simultaneous exploration of all detected precursors and fragments during data processing, employing the widely-used open-source MZmine 3 software. It was applied to a dataset of six Ocotea plant species. This framework suggested 49 flavonoids potentially newly described for these plant species, alongside 45 known features within the genus. Flavonols kaempferol and quercetin, both exhibiting O-glycosylation patterns, were particularly prevalent. Gas-phase fragmentation reactions further supported these findings. For the first time, the apigenin flavone backbone was also annotated in most of the examined Ocotea species. Apigenin derivatives were found mainly in the C-glycoside form, with O. porosa displaying the highest flavone : flavonol ratio. The approach also allowed an unprecedented detection of kaempferol and quercetin in O. porosa species, and it has underscored the untapped potential of LC-MS/DIA data for broad and reliable flavonoid profiling. Our study annotated more than 50 flavonoid backbones in each species, surpassing the current literature.


  • Open Access

    Integrative open workflow for confident annotation and molecular networking of metabolomics MSE/DIA data

    by Albert Katchborian-Neto, Matheus F Alves, Paula C P Bueno, Karen de Jesus Nicácio, Miller S Ferreira, Tiago B Oliveira, Henrique Barbosa, Michael Murgu, Ana C C de Paula Ladvocat, Danielle F Dias, et al.

    Liquid chromatography coupled with high-resolution mass spectrometry data-independent acquisition (LC-HRMS/DIA), including MSE, enable comprehensive metabolomics analyses though they pose challenges for data processing with automatic annotation and molecular networking (MN) implementation. This motivated the present proposal, in which we introduce DIA-IntOpenStream, a new integrated workflow combining open-source software to streamline MSE data handling. It provides ‘in-house’ custom database construction, allows the conversion of raw MSE data to a universal format (.mzML) and leverages open software (MZmine 3 and MS-DIAL) all advantages for confident annotation and effective MN data interpretation. This pipeline significantly enhances the accessibility, reliability and reproducibility of complex MSE/DIA studies, overcoming previous limitations of proprietary software and non-universal MS data formats that restricted integrative analysis. We demonstrate the utility of DIA-IntOpenStream with two independent datasets: dataset 1 consists of new data from 60 plant extracts from the Ocotea genus; dataset 2 is a publicly available actinobacterial extract spiked with authentic standard for detailed comparative analysis with existing methods. This user-friendly pipeline enables broader adoption of cutting-edge MS tools and provides value to the scientific community. Overall, it holds promise for speeding up metabolite discoveries toward a more collaborative and open environment for research.


  • Bioprospecting-based untargeted metabolomics identifies alkaloids as potential anti-inflammatory bioactive markers of Ocotea species (Lauraceae)

    by Albert Katchborian-Neto, Karen de Jesus Nicácio, Jonas C. Cruz, Paula Carolina Pires Bueno, Michael Murgu, Danielle F. Dias, Marisi G. Soares, Ana C.C. Paula, Daniela A. Chagas-Paula